Skip to content

Open nowPosted 9 hours ago

Research Associate 1 or 2, Biology (12 Month Contract)

Xenon Pharmaceuticals33 open roles

Pay
CA$58,100 – CA$81,000 a year
Where
Vancouver
Work mode
On site
Get the CV for this job

From $25 per CV, paid once. No subscription.

Your applicationOpen nowResearch Associate 1 or 2, Biology (12 Month Contract)Xenon Pharmaceuticals · Vancouver
  1. YouYes, apply to this one.

  2. CV RocketCV written for this posting.

  3. 25 readersRecruiter, hiring manager, skeptic. Round after round.

  4. CV RocketApplied on Xenon Pharmaceuticals's own form.

The reply lands in your private mailbox

3×more interviews than doing it yourself with ChatGPT.

The clock on this job

Early applications get read.

8.2% of postings close within 7 days. Measured by our own scanner across the market. Xenon Pharmaceuticals postings stay open a median of 1 days.

Share of postings closed within
  1. 1.8%1 day
  2. 3.6%3 days
  3. 8.2%7 days
  4. 15.2%14 days
  5. 34.0%30 days
This job: posted 9 hours ago

Xenon Pharmaceuticals median: 1 days open

The posting

Who We Are:

Xenon Pharmaceuticals (NASDAQ:XENE https://www.nasdaq.com/market-activity/stocks/xene) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.

What We Do:

We are advancing an exciting product pipeline https://xenon-pharma.com/pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we submitted a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting. We continue to advance an early-stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 and XEN1720 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are being developed for pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.

We are seeking Research Associate 1 or 2, Biology with experience in brain slice electrophysiology to join our team for a 1-year contract. The candidate must be interested in neuroscience and/or pharmacology with a knowledge of electrophysiology to work with cutting edge techniques in our industry lab setting. The candidate will perform patch clamp electrophysiology experiments in acute rodent brain slices to characterize the effects of novel compounds on neuronal excitability and ion channel function. The successful candidate will also support a range of neuroscience research activities, including viral injections in neonatal mice, imaging-based assays, tissue processing and cross-functional ex vivo pharmacology efforts. . This candidate will join a passionate, diverse, and dynamic team focused on developing treatments for epilepsy and other neurologic conditions.

The Research Associate 1 or 2, Biology will report to the Senior Research Scientist, Biology and be based out of Vancouver, BC, Canada. The level of the position will be commensurate with the candidate’s education and industry experience. On-site positions require up to five on-site days per week.

RESPONSIBILITIES:

· Independently design and execute electrophysiological recordings from brain slices.

· Aid the ex vivo team in performing viral injections in neonatal mice for expression of various exogenous proteins, such as fluorescent markers or opsins.

· Conduct tissue culture, immunohistochemistry and fluorescence microscopy as required.

· Collaborate with cross-functional teams to support target validation and translational neuroscience studies.

· Keep up to date and detailed records of experiments and data analysis.

· Report writing, documentation and presentations including detailed write-ups of functions and capabilities of newly developed analysis toolboxes.

· Ensure the laboratory environment safe and well-organized; follow and keep up to date with Health & Safety; other general lab maintenance duties.

· Keep up to date and detailed records of experiments and data analysis within an Electronic Lab Notebook system. Ensure experiments are counter-signed on a monthly basis.

· Ensure the laboratory environment is safe and well-organized; follow and keep up to date with Health & Safety policies.

· Act in accordance with Company policies, including, for example, the Code of Business Conduct and Ethics and ensure policies are understood and followed by direct reports, if any

· Other duties as assigned

QUALIFICATIONS:

· A minimum bachelor’s or master’s degree in Neuroscience or Pharmacology or related field with up to two years of relevant experience.

· Prior practical experience with brain slices and electrophysiology is required.

· Excellent oral and written communication skills and takes initiative.

· Excellent record keeping and attention to detail.

· Prior experience with microscopy, immunohistochemistry is a plus.

· Knowledge in the study of ion channels and pharmacology is a plus.

· Knowledge and practical experience with current/voltage clamp approaches in the study of ion channels and pharmacology will be a plus.

· Knowledge in in silico modeling to complement our drug efforts is a plus.

Our Total Rewards program includes base salary, target bonus, and stock options, as well as a full range of benefits including medical, dental, vision, short-& long-term disability, accidental death & dismemberment, and life insurance programs, Employee Assistance Program, travel insurance, and retirement savings programs with company matching contributions.

Xenon encourages time to rest and re-charge through vacation, personal days, sick days, and an end-of-year company shutdown. Xenon highly values employee development and has an expanding Training, Learning & Development program, including a Tuition Assistance program for advanced degrees.

From $25, paid onceGet the CV for this job

What happens when you press

One press. We do the rest.

  1. A CV for this posting

    Written against Xenon Pharmaceuticals's own wording, from every piece of relevant proof in your profile.

  2. 25 readers review it

    Recruiter, hiring manager, skeptic and more read every draft, round after round. You get the best round.

    The review screen in CV Rocket: how each CV was read, round by round.
  3. We apply on Xenon Pharmaceuticals's form

    Our application engine gets through the hardest forms there are. Where a question needs you, AI suggests the best answer. Don't want us applying from our IP addresses? Use our Chrome extension: we apply straight from your own browser.

    An application in CV Rocket: every answer filled in on the employer's form.
  4. Every reply, sorted

    Xenon Pharmaceuticals's answer lands in your private mailbox, and we classify it on arrival: interview, question, rejection.

    The CV Rocket inbox: each employer reply classified as an interview, an action or a rejection.
  5. Reply with AI

    AI helps you write the email, checks it and sends it. We show you whether the recruiter read it.

  6. The interview in your calendar

    Full integration with your calendar. The invitation goes straight in.

    An interview invitation in the CV Rocket inbox, added to the candidate's calendar.
Get the CV for this job

From $25 per CV, paid once. No subscription.

Why it works

3×

more interviews than doing it yourself with ChatGPT.

ChatGPT writes a CV and never learns what happened to it. We see every reply. For each CV we know:

  • How it was written, and how the review scored it
  • When we applied, and how long after the posting went up
  • Which posting, which company, which city
  • Who got the interview, and who heard nothing

That is how we know which CVs get called.

Get the CV for this job

From $25 per CV, paid once. No subscription.

The numbers game

More applications. More interviews.

Every application goes out with its own CV, written for that posting and paid once. Send enough of them and the law of large numbers finds you the job.

By hand5–10
With CV Rocket100
applications a day

Before you press

Straight answers

Get the CV for this job

From $25 per CV, paid once. No subscription.

What if my background isn't good enough?

We make the most of the background you have. The CV uses every piece of relevant proof your profile holds, and one of the 25 readers reads your whole profile and flags what the CV left out.

Do you really apply for me?

Yes, on the employer's own form, the hardest ones included. Where a question needs you, you answer it right there and AI suggests the best answer. Don't want us applying from our IP addresses? Use our Chrome extension: we apply straight from your own browser.

Is it a subscription?

No. You pay once per CV, from $25. Every application goes out with its own CV, written for that posting.

One job. One CV.
Paid once.

Pick the posting you want. We write for it, apply for you and catch the reply.

Get the CV for this job

From $25 per CV, paid once. No subscription.